DIABETES TEST KIT

MANUFACTURING
INDUSTRY ANALYSIS

STRATEGIC MANAGEMENT 1
SECTION A | GROUP 9
IIM RAIPUR

Submitted by:
Anshoo Saini

15PGP008

Gautham Balaji
15PGP015
Isha Tayal
Koundinya Niggamadda
15PGP026
Piyush Gaurav
15PGP037

15PGP018

Index
Industry
Definition
.2
Industry Activities.................................................................................................. 2
Similar Industries................................................................................................... 2
Market Participants................................................................................................ 2
Porters Five Forces Analysis.................................................................................. 3
PESTEL Analysis..................................................................................................... 4
Industry Outlook.................................................................................................... 5
Products & Markets................................................................................................ 6
Future Outlook....................................................................................................... 7
Competitive Landscapes, Success factors and Business Locations.......................7
Major Companies................................................................................................... 8
Strategic Recommendations................................................................................10

IIM RAIPUR

Page 1

Industry Analysis
Industry Definition
This industry develops and produces blood glucose meters and testing supplies
that help users monitor blood glucose levels. Most manufacturers also develop
other medical devices.

Industry Activities

Diabetes market research

Glucose meter monitoring research and development
Glucose meter
Glucose meter accessory

Similar Industries

Dental Laboratories
Diagnostic & Medical Laboratories
Dialysis Equipment Manufacturing
Health & Medical Insurance
Hearing Aid Manufacturing
Medical Device Manufacturing
Medical Instrument & Supply Manufacturing
Ophthalmic Instrument Manufacturing
Pacemaker Manufacturing
Robotic Surgery Equipment Manufacturing
Syringes & Injection Needle Manufacturing
TENS Machine Manufacturing
Venous Access Device Manufacturing

Market Participants

R&D
Suppliers
Manufacturers
Hospitals
Doctors
Patients
Retailers

IIM RAIPUR

Page 2

Porters Five Forces Analysis

Internal Rivalry: The market is highly competitive and commoditized though it

involves a considerable cost in coming up with any innovative kit. The currents
products like blood glucose meter, Glucose meter test strips, lancets and Insulin
pens are produced by many companies. Accu-Chek Compack Plus, One Touch
Ultramini, Fora V30 etc are example of few successful products by various
companies. A considerable amount of money (often running in billions) is
involved in coming out with any new, more effective kit. However, most of
companies are producing more or less same type of kits with little differentiation.
A significant cost is involved in marketing the products, out of which
advertisements take a major chunk.
New Entry: Though entry into pharmaceuticals sector involves a large cost, the
cost for setting up a base for producing these kits is considerable low. Any small
time pharma with little know-how can venture into these segments. Since the
segment shows considerable growth projections in future, raising funds for such
kits is not difficult. Designing and manufacturing of kits can also be outsourced
to have competitive cost advantage. If a company develops any new method or
kit, it can protect it with IPRs but that does not defer other from entering the
market.
Substitutes/Complements: There are tough competitions in market for
providing medication for controlling diabetes. An array of products is offered
across various clans of medical area. Allopathy, Ayurveda, Homoeopathy etc
IIM RAIPUR

Page 3

have their own sets of recommendations. However, there are almost no

substitutes for these kits. These kits can be personally used. A close substitute is
provided by lab tests which considerably slow and does not have same position
as that of these kits.
Buyer Power: Buyer have always had low bargain power in pharmaceutical and
medicinal products, as there are low-to-no substitutes available but such
products are very essential for them. Taking advantage of this, pharmaceuticals
and medicine companies have been able to charge high prices, in order to
compensate for R&D costs. The customer base for companies such kits are retail
drug stores, hospitals, and government medical institutions. Though retail outlets
do not have much power, hospitals and government institutes can have a
bargaining stand. They may seek discounts on bulk purchase.
Supplier Power: The development of these kits is mostly outsourced and
companies always have options to switch to other suppliers as switching cost is
not so high. Giants can also go for horizontal integration and hence the
companies have high bargain power in comparison to suppliers.

PESTEL Analysis

Political: There is increase in political pressure on healthcare industry. Since

there has been considerable increase in cases of diabetes in India (prevalence
rate of around 9%), government can act as a benefactor in making these basic
amenities available to most. There can also pressure on pricing. There can be
schemes of providing insurance to common public.
Economic: Since the diabetes is also becoming quite prevalent in middle and
low income class, we may see some insurance models come in picture to handle
such costs. With an increase in no. of buyers and these products being a
IIM RAIPUR

Page 4

commoditized one, the companies may be forced to cut back more prices to stay
competitive. There can also M&A where small players will be bought by bigger
ones.
Social/Cultural: With the aging population of India, there will be surge in
diabetic cases (as diabetic is seen mostly in older people). This offers both
opportunities as well as threats. Patients are becoming more informed and
demanding.
Technological: There is high need of technological innovation this field. The
field is lucrative in terms of returns on investment. This can lead to some new
products with better accuracy. Any app or a bloodless service can also come into
picture. There are also many opportunities where information and
communication technologies can be used to divide the sections of patient and
provide customised and cheaper service. A private consultation service may be
given after each test by these test kits.
Legal: There are many legal and regularity issues in this field. However, they are
quite relaxed for these kits as they do not pose severe health hazards and are
not used for medication but for monitoring the glucose level only.
Environmental: There are not much of environmental ill-effects due to these
kits. However, companies can be forced to find ways to effectively dispose the
used test kits and elements of CSR can also come into picture.

Industry Outlook
Diabetes care market mainly consists of devices, technologies and therapeutics
markets related to diabetes. Diabetes market in India is expected to reach USD
2.3 Billion by 2020 and is expected to grow at a CAGR of 6.3%.
The diabetes patient pool worldwide is expected to be 380 million by 2025. The
growth rate can be mainly attributed to the increase in aging population,
sedentary lifestyle, dietary patterns that are unhealthy etc. Diabetes care shares
approximately 11.6% of the global healthcare expenditure. Global diabetes care
product market was around USD 41 billion in 2012.
The primary market drivers for the diabetes care industry will be the large
patient pool suffering from diabetes, sedentary lifestyle of people, obesity and
growth in innovation technologies, more Research & Development in diabetes
diagnosis and treatment and non invasive products. Moreover increase in
adoption rates for diabetes care devices will be driven by growth in awareness,
improved diagnosis and treatment rates and increase in need for faster, safer
and effective diagnosis method and diabetes treatment.
In addition to that, ability to invest more by the market leaders and entry of new
firms into this market, increase in scope of getting in untapped and emerging
IIM RAIPUR

Page 5

markets, and increase in awareness among people about diabetes care are also
opening up the growth of this market. Also there has been a substantial increase
in the number of diabetes cases reported globally over the past few years.
However, there are few factors that hinder the growth of the diabetes care
market. They are mainly high cost associated with diagnosis and treatment,
contention on reimbursement for new technologies, dearth in awareness, strict
regulatory compliance, and high cost of diabetic food. Third party
reimbursements are restricted to the coverage type they give to concerning
devices, diagnosis and treatment of diabetes.

Products & Markets

The main products under diabetes care are the following

Blood Glucose Monitoring Devices

o Testing Strips
o Self-monitoring Blood Glucose Meters
o Lancets
o Continuous Glucose Monitors
o Others
Insulin Delivery Devices
o Insulin Syringes
o Insulin Pens
o Insulin Pumps
o Insulin Jet Injectors
Other
o
o
o

Glucose Testing Devices

Hemoglobin A1c
Hemoglobin A1c Meters
Hemoglobin A1c Kits

Market is divided into two major segments. They are mainly glucose monitoring
device market and insulin delivery device market. Glucose monitoring device is
further divided into blood glucose meters, blood glucose testing strips, lancets,
and CGM device. Also, Insulin delivery device is further segmented into Insulin
syringes, Insulin pens, Insulin pumps and Insulin Injectors.
Global SMBG equipment markets value has been valued to reach approximately
USD 27 billion in 2022. There is an increase in availability of blood glucose
meters in India but the main huddle faced by their penetration is their high
priced.
The testing strips segment holds for the highest share of the blood glucose
monitoring devices market and the insulin pens segment holds the largest share
of the insulin delivery devices market. The greater share of the insulin pens
segment is mainly because of the high adoption rate of insulin pens .The growth
in taking over of insulin pens and easy accessibility of affordable insulin pens in
India which was recently introduced have added to the growth of this segment.
IIM RAIPUR

Page 6

CGM systems recently became one of the fastest growing blood glucose
monitoring devices market segment. Growth in this segment is mainly because
of the rising adoption CGM systems by healthcare professionals to monitor realtime blood glucose levels for better care and treatment of diabetes
The usage of Continuous Glucose Monitoring devices are increased over the
years but saw growth of just fewer than 20 percent in 2012.Insulin delivery
device landscape will allow for strong growth and the insulin syringe patient
share have a probability to decrease. The insulin pen and insulin pump patient
share may see substantial growth over the next few years.

Future Outlook
One of the recent initiatives involves a glucose sensing technology, which uses
tears or sweat to detect glucose levels instead of blood. A wireless device
integrating the biosensor is also being developed. Continuous monitoring of
glucose levels and transmission of the data to a glucose pump for a completely
integrated treatment will be possible because of these innovations. A biosensor
for blood glucose that involves measurement and analysis through digital means
is also being developed.
Also the launch of Code-free meter by some of the companies has reduced errors
in coding and has discarded the need for patients buying new box of strips each
time. Higher income levels and plunge in prices of glucose meter have been
playing an important role to push their widespread use. The market is expanding
faster in tier-II and tier-III towns and would see a quicker growth with changing
lifestyle. Although India has a bigger market size, 99.9 percent demand of Indian
diabetes market is satisfied by only imports, and the governments effort to
improve local manufacturing has been still facing huddles so far.

Major Companies
Roche Diagnostics
Founded in Switzerland in 1896, Roche is a pioneer in healthcare for nearly 120
years. It has discovered innovative pharmaceuticals and diagnostics that are
used by millions of patients in the world. It is the global leader in cancer
treatments and leading provider of in vitro diagnostics. Roche Diagnostics
currently operates from five Offices in India with the Offices at Chennai, Kolkata,
Mumbai (Andheri Office) and New Delhi serving the Diagnostics while the
Mumbai (Bandra office) serves pharmaceuticals.
The company has more than 35 years of experience in the area of diabetes
management and serves the Patients through the product line Accu Check under
which it offers products like Glucose Meters-Active and Aviva, Softclix Lancets,
Meter Strips Accu-Chek-Active, Aviva and Performa. Accu Check is No.1 Brand in

IIM RAIPUR

Page 7

blood glucose monitoring systems worldwide. It sells its products through etailers
like e-bay.
Johnson and Johnson
Established in 1886, with experience of over a century, Johnson and Johnson is
the Worlds sixth largest Consumer health company and most comprehensive
medical devices business. The Medical Devices business segment produces a
broad range of innovative products and solutions used primarily by health care
professionals in the fields of orthopaedics, neurological disease, vision care,
diabetes care, infection prevention, diagnostics, cardiovascular disease, and
aesthetics. Johnson and Johnson produced the first full feature insulin pump that
wirelessly communicates with a blood glucose meter-remote. The system allows
a person to calculate and opt to wirelessly deliver insulin doses without touching
the pump at all, giving patients more freedom, discretion, and flexibility. Johnson
and Johnson OnetouchUltraeasy Glucometer is currently available in India
through varies etailers with a price range of Rupees 900-1200
Abbott
Founded in 1888, by a young Chicago based physician, Dr. Wallace Calvin Abbott,
the organization has been devoted to discovering new medicines, new
technologies and new ways to manage health. Today, it is a worldwide broad
based healthcare company whose products and technologies span the
continuum of care - from diagnostics to devices, from nutrition to pharmaceutical
therapies.
Headquartered in Mumbai, Abbott India Limited, a publicly listed company and a
subsidiary of Abbott Laboratories, enjoys strong brand equity in multiple
therapeutic categories such as Women's Health, Gastroenterology, Neurology,
Thyroid, Diabetes & Urology, Pain Management, Vitamins, Anti-Infective& other
therapy areas. It employs over 2,600 people and reaches customers through a
network of 35 distribution points, catering to over 4,500 stockists and 150,000
retail outlets.
The company has in-house development and medical teams to undertake
product and clinical development tailored to needs of the Indian market. It
reaches the patients. Its key products include the XIENCE drug-eluting stent,
laboratory diagnostic instruments ARCHITECT and AxSYM, and blood glucose
monitoring devices for diabetes, Free Style Optium and Free Style Freedom Lite.
As quoted by diabetes daily, the brand freestyle (of Abbott) is rated the best
among glucose meters scoring excellent in accuracy, with a rating more than 80
out of 100.
Arkay
Established in 1960 by Mr.TadashiDoi as KDK Corporation in Kyoto, ArkayInc
today operates in two business segments Development and New Business. The
company has its products for Laboratory Testing, Near Patient testing, Blood
IIM RAIPUR

Page 8

Glucose Monitoring, Span Diagnostics and other products like the Blood Pressure
Monitor, Insulin cool Punch etc..,
Pulsatom Healthcare
Incorporated in February 1994, with its factory and headquarters at Bengaluru,
Pulsatom healthcare is the manufacturer of Indias first Indigenous Glucometer.
With its goal of a Healthy India, the company specialises in point-of-care testing
devices. It started manufacturing and introduced India's first indigenous
Glucometer in 1995 with technology developed by National Physical Laboratory
& Centre for Bio-chemical Technology, Delhi under C.S.I.R. Labs, Department of
Science and Technology, Government of India. Across 20 years, it has launched
over seven models to meet your need for a reliable yet economical Self
Monitoring Blood Glucose Meter.
Currently the company offers RP 10 Glucometer and RP 50 Glucometer products
under the Brand name ACE priced at Rs.800 and 1200 respectively where the
numbers 10 and 50 specify the number of Strips in the Product. Headquartered
at Bangalore, the company has its current dealer bases extend to over 100
dealers in India reaching across most major regions of the country. The company
also sells its products through etailers like flipkart and Amzon in addition to its
own website (https://www.pulsatom.com/estore.asp)
Other prominent products under the brand names Arkray, B.Braun, Glucocare,
JSB, Diabascan, Nipro, Omron, Dr.Gene, Dr.Morepen, Besure, Beurer, Operon,
RomsonsRomo, Truworth etc..,

Competitive Landscapes, Success factors and Business

Locations
These are few market players in the segment working in India. In the following
section we have discussed about the competitive landscapes, key success
factors and business locations used by these players.
Roche
The Company is world leader in healthcare sectors of pharmaceuticals and
diagnostics headquartered in Basel, Switzerland. It focuses on the strategy that
aims at providing health care services for improvements in quality and survival
of patients life. The company was founded in 1896 and since then some twentyeight medicines developed by it have been registered in World Trade
Organization Model list.
Company has expended into India with a brand name of Accu-Chek. It has its
main office in Mumbai and supplies the products on pan India basis. It has an
experience of 35 years on Indian soil and became a pioneer in diabetes
management. It plays market penetration strategy by making its product such as

IIM RAIPUR

Page 9

lancets and glucometers widely available in the market and widely accessible by
doctors and patients.
Omron
The journey began from 1933 with the founder Kazuma Tateisi and headquarters
in Kyoto, Japan. It has a simple strategy that can be summed up in three stages
improving productivity, improving peoples day-to-day life and creating new
relationships between machines and employees. The company strives in search
of new solutions to health and safety need of the people. It commenced its
operation in India in 1980 with the products such as glucometer and lancets. It
presently has offices in Gurgaon, Mumbai and Bangalore. The company senses
its strength in innovation of new technologies.
Pulsaton Health Care Pvt. Ltd.
The Company established in the year 1994 is headquartered in Bengaluru. This
Indian based company deals in glucometer with its production unit in Bengaluru.
It has collaborated with other firms to become best in the field of sales and
support across India through more than 100 dealers. It has also partnerships with
e-retailers such as Amazon, Flipkart, Healthkart etc.
Operon
This is a new Indian company, came into existence recently in 2008 with
headquarters in Bengaluru. The company carries a workforce of experienced
professionals and aim for innovation and growth in health sector od the country.
The key strengths of the company are strong product line, quality products,
excellent technical and customer support.
Alere
A United States based company with operations across the global is also serving
India since its inception in 2001. Few strategies followed by the company are
socially conscious business approach, cost effectiveness and wide availability. It
commits for high quality products and services with continuous advancement in
technology to sustain in the market. The Indian league of the company has
offices in Manesar and Gurgaon.
JSB Health care
The biggest player in Indian market headquartered in New Delhi has experience
of over 30 years in this business. Company has efficiently used its online portal
for faster and free deliveries across the nation. Moreover it has tie-ups with other
interesting e retailers such as Airline and Railway Catalogue, Tele shopping and
corporate gifting. Among most of the Asian countries, company has also
extended its business to African and European continent to have a global
presence. It is a one stop shop for all the medical needs in a reasonable price.

IIM RAIPUR

Page 10

Strategic Recommendations
The business of Self-Monitoring of Blood Glucose (SMBG) is highly competitive in
nature. Without innovating on the technology used, the new entrants will find it
hard to sustain and succeed in this market. The prices per unit of the glucose
meter/ strips are likely to decline, adding to their troubles.
In order to sustain growth and maintain adequate profit margins, we have the
following recommendations for the existing players in SMBG business:
Create better effective and economical monitoring techniques to manage
diabetes and thereby focus on diagnostic development for the potentially
untapped global market
Use of R&D to develop better ways of continuously monitoring glucose
level in vivo
Develop technologies involving mobile phones and applications as the
basic glucometer instrument to enable tech savvy consumer base to
effectively monitor their glucose levels.
Partnership with insulin pumps and pens can enable automated disease
management by continuous glucose monitoring.
Tight glycemic control should be focused on when educating the patient
about managing diabetes.

IIM RAIPUR

Page 11

References
https://www.diabetesdaily.com/blog/2015/06/consumer-reports-glucosemeter-ratings-2015/)
https://www.ibisworld.com/industry/glucose-meter-manufacturing.html
http://www.medicalbuyer.co.in/index.php?
option=com_content&task=view&id=4567
http://www.diabetesmonitor.com/glucose-meters/blood-glucose-metertrends.htm
http://www.marketresearch.com/product/sample-6921302.pdf

IIM RAIPUR

Page 12